In this episode, we will discuss the unique biology of tRNA and how it can be leveraged to scale the development of genetic medicines.
This conversation features Michelle Werner, CEO of Alltrna and CEO-Partner at Flagship Pioneering, and Caroline Köhrer, Vice President, Discovery Platform at Alltrna.
